- Opyl Limited, an Australian biotech company, bought around 2 Bitcoin as part of a new treasury strategy during financial hardship.
- The company got a non-dilutive loan from non-executive director Antanas “Tony G” Guoga, backed by its Bitcoin holdings.
- Opyl’s stock price spiked more than 47% after the announcement but remains down over 68% from five years ago.
- Opyl ended the last quarter with only $41,700 in cash and said it has less than a month of funding left.
- This move follows a growing trend of struggling public companies investing in Bitcoin as a possible financial lifeline.
Opyl Limited, an AI-focused biotech firm based in Melbourne, announced on Thursday that it adopted a Bitcoin treasury strategy after experiencing significant financial stress. The company purchased about two Bitcoin, valued at approximately $214,500, through the DigitalX Bitcoin ETF listed on the Australian Securities Exchange.
After revealing the Bitcoin acquisition, Opyl’s share price rose more than 47%, according to Yahoo Finance, although the stock is still significantly lower than levels five years ago. The company reported ending the March quarter with only $41,700 in cash and had a funding runway of less than a month.
The purchase was supported by a non-dilutive loan with a 6.5% interest rate from non-executive director Antanas “Tony G” Guoga. The loan, which is capped at $1.3 million, is secured by the company’s Bitcoin holdings. Opyl stated the decision aimed to strengthen its treasury diversification and demonstrate a commitment to shareholder value.
Quarterly financial filings show the company had just $1,300 in receipts during the period and $170,000 in operating outflows, while a licensing deal worth $978,400 is still pending. Opyl also allowed 5 million options to lapse to meet performance conditions (ASX filing).
Experts cited in the article, such as Mike Eli of Coinperps, noted that more public companies globally are investing in Bitcoin reserves amid financial distress and market unpredictability. Eli pointed to data showing up to $500 million in daily net inflows for Bitcoin ETFs since April (data). He said firms are attempting to benefit from Bitcoin’s speculative gains, referencing similar moves by companies like Strategy, Metaplanet, and Semler Scientific.
However, Eli cautioned that this approach is risky and might be more of a short-term tactic than a reliable turnaround method. He said, “competition and potential downturns could trigger forced liquidations and instability.” Opyl maintains that its move is a step toward careful, future-minded capital management, but the company acknowledges Bitcoin could be its last chance to survive in the short term.
Guoga advised investors to, “take the time to fully understand” cryptocurrencies, saying digital assets are increasingly recognized as a forward-looking class by institutions and governments.
✅ Follow BITNEWSBOT on Telegram, Facebook, LinkedIn, X.com, and Google News for instant updates.
Previous Articles:
- Theta Network Launches EdgeCloud Beta, Unveils Hybrid GPU Platform
- Australian Police Crack Down on Crypto ATM Scams, Contact 90 Users
- Colorado Pastor Faces Judgment Over “Divine Wealth” Crypto Scam
- Theta EdgeCloud Hybrid Beta Launches, Ushering in Decentralized AI
- Bitcoin Surges 10% as Middle East Tensions Ease, Hits $108,200
